2025-04-29 20:55:22
Latest Post
Atishay Ltd Q4 FY2025 net profit at Rs. 2.36 crore
Schaeffler India Ltd posts consolidated PAT of Rs. 251.62 crores in Q1 CY2025
IndoStar Capital Finance Ltd Q4 FY2025 consolidated profit increases to Rs. 36.19 crores
IndiaMART InterMESH Ltd Q4 FY25 consolidated PAT soars to Rs. 180.6 crores
Aryaman Capital Markets Ltd Q4 FY2025 PAT jumps to Rs. 16.99 crores
Stock Report
AstraZeneca Pharma India Q3FY22 net profit lower at Rs. 11.41 crores
Posted On : 2022-02-08 21:34:10( TIMEZONE : IST )
AstraZeneca Pharma India Limited has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 205.8578 crores during the period ended December 31, 2021 as compared to Rs. 200.5509 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 11.4192 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 11.9470 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 4.57 for the period ended December 31, 2021 as compared to Rs. 4.78 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 205.8578 crs | ₹200.5509 crs |  2.65% |
| Net Profit | ₹11.4192 crs | ₹11.9470 crs |  -4.42% |
| EPS | ₹4.57 | ₹4.78 | -4.39% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 205.8578 crores during the period ended December 31, 2021 as compared to Rs.203.1802 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.11.4192 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.21.0516 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.4.57 for the period ended December 31, 2021 as compared to Rs.8.42 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 205.8578 crs | ₹203.1802 crs | 1.32% |
| Net Profit | ₹11.4192 crs | ₹21.0516 crs | -45.76% |
| EPS | ₹4.57 | ₹8.42 | -45.72% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.584.7105 crores during the 9 Months period ended December 31, 2021 as compared to Rs.613.5955 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.33.6095 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.66.0246 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.13.44 for the 9 Months period ended December 31, 2021 as compared to Rs.26.41 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹584.7105 crs | ₹613.5955 crs | -4.71% |
| Net Profit | ₹33.6095 crs | ₹66.0246 crs | -49.10% |
| EPS | ₹13.44 | ₹26.41 | -49.11% |
Shares of AstraZeneca Pharma India Limited was last trading in BSE at Rs. 2767.60 as compared to the previous close of Rs. 2783.25. The total number of shares traded during the day was 1093 in over 549 trades.
The stock hit an intraday high of Rs. 2814.00 and intraday low of 2728.45. The net turnover during the day was Rs. 3018144.00.
